Document text
Principal Investigator: BRIAN M BARNES
Organization: UNIVERSITY OF ALASKA FAIRBANKS
Fiscal Year: 2021
Award: $128,440
Funding agency: National Institute of General Medical Sciences
Project Summary: To date (3/23/21), Alaska has suffered over 58,000 cases of COVID-19,
1,318 hospitalizations, and 306 deaths. Alaska is a designated Primary Care Health
Professional Shortage Area. Likely driven by health disparities, the COVID-19 fatality rate
among American Indian/Alaska Native (AI/AN) residents of Alaska is nearly two times higher
than the population of Alaska as a whole (71 v. 47 per 100,000; Alaska DHSS Bull. 1/29/21), a
pattern observed in AI/AN population nationwide (CDC MMWR 12/11/20). Even with these
challenges, Alaska has one of the lowest COVID-19 hospitalization and fatality rates overall,
and one of the highest rates of COVID-19 vaccination.
Sequencing of SARS-CoV-2 genomes has emerged as the key technology for analyzing spread
of SARS-CoV-2 lineages, including detection of VOC that may cause more rapid spread, more
severe disease, or reduce vaccine efficacy. Importantly, through early capacity-building by the
Alaska DHSS Public Health Lab (PHL), in partnership with the University of Alaska and Alaska
INBRE, over 500 SARS-CoV-2 genomes have been sequenced and released (GISAID),
including recent cases of B.1.1.7, B.1.429, and P.1 variants of concern (VOC). Thus, it is
important to understand the geographical and temporal spread of SARS-CoV-2 lineages in the
state, and specifically in the AI/AN population.
In response to this NIGMS NOSI, the Alaska INBRE (IDeA) program is proposing to extend the
genomic surveillance for SARS-CoV-2 lineages and variants in Alaska, with a team of University
of Alaska researchers (at UA-Fairbanks and UA-Anchorage), in collaboration with the
Southcentral Foundation (SCF) and Alaska Native Medical Center (ANMC) AI/AN health
networks, and support from other partners including the Alaska DHSS PHL and CDC Arctic
Investigations. The project goals are (1) Prospective genomic sequencing of VOC and VOI in
Alaska and comparison to other regions; (2) Prospective genomic sequencing of VOC/VOI in
AI/AN health networks to understand COVID-19 disparities; and (3) Geographic and temporal
analysis of SARS-CoV-2 in Alaska to inform epidemiological understanding. We will leverage
both short-read (Illumina) and long-read (Nanopore) sequencing platforms, and bioinformatics
expertise built by Alaska INBRE, to analyze SARS-CoV-2 genomes with samples provided by
Alaska DHSS/PHL, and specifically in AI/AN (SCF and ANMC served) populations. Data will be
released for meta-analyses to provide genomics perspective to epidemic tracing, understanding
of spread of novel lineages, and impact of health disparities.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV variant><2019-nCoV variant forms><2019-nCoV variant strains><21+ years old><Address><Adult><Adult Human><Alaska><Alaska Indian><Alaska Native><Alaskan American><Alaskan Indian><Alaskan Native><Alaskan Native American><American Indian><American Indians><Archives><Arctic><Arctic Regions><Awareness><B.1.1.7><Back><Bio-Informatics><Bioinformatics><Biomedical Research><Blood Circulation><Bloodstream><CDC><COVID><COVID crisis><COVID epidemic><COVID pandemic><COVID-19><COVID-19 associated death><COVID-19 associated fatality><COVID-19 associated mortality><COVID-19 crisis><COVID-19 death><COVID-19 disparity><COVID-19 epidemic><COVID-19 fatality><COVID-19 genome><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 induced death><COVID-19 induced fatality><COVID-19 induced mortality><COVID-19 mortality><COVID-19 pandemic><COVID-19 positive><COVID-19 positivity><COVID-19 public health crisis><COVID-19 related death><COVID-19 related fatality><COVID-19 related mortality><COVID-19 surveillance><COVID-19 testing><COVID-19 vaccination><COVID-19 variant><COVID-19 variant forms><COVID-19 variant strains><COVID-19 virus><COVID-19 virus genome><COVID19><COVID19 associated death><COVID19 associated fatality><COVID19 associated mortality><COVID19 crisis><COVID19 death><COVID19 disparity><COVID19 epidemic><COVID19 fatality><COVID19 genome><COVID19 global health crisis><COVID19 global pandemic><COVID19 health crisis><COVID19 induced death><COVID19 induced fatality><COVID19 induced mortality><COVID19 mortality><COVID19 pandemic><COVID19 positive><COVID19 positivity><COVID19 public health crisis><COVID19 related death><COVID19 related fatality><COVID19 related mortality><COVID19 surveillance><COVID19 testing><COVID19 vaccination><COVID19 virus><COVID19 virus genome><CV-19><CV19><Centers for Disease Control><Centers for Disease Control and Prevention><Centers for Disease Control and Prevention (U.S.)><Cessation of life><Circulation><CoV disease><CoV-2><CoV2><Collaborations><Communication><Data><Death><Detection><Diagnostic><Disease><Disease Outbreaks><Disorder><Dorsum><Epidemic><Epidemiology><Evaluation><Event><Fatality rate><Foundations><Funding><Genbank><Genetic><Genome><Genomics><Geographic Area><Geographic Distribution><Geographic Locations><Geographic Region><Geographical Location><Geography><Goals><Health><Health Care Providers><Health Personnel><Health Services><Healthcare Provider Shortage Areas><Healthcare Providers><Healthcare worker><Hospital Admission><Hospitalization><Indigenous Population><Investigation><Investigators><Knowledge><Lead><Medical center><Meta-Analysis><Molecular><NIGMS><National Institute of General Medical Sciences><Native People><Native-Born><Outbreaks><Pattern><Pb element><Performance><Population><Primary Care><Primary Health Care><Primary Healthcare><Public Domains><Public Health><Public Health Service><Reporting><Research Infrastructure><Research Personnel><Research Specimen><Researchers><SARS corona virus 2><SARS-CoV-2><SARS-CoV-2 B.1.1.7><SARS-CoV-2 associated death><SARS-CoV-2 associated fatality><SARS-CoV-2 associated mortality><SARS-CoV-2 death><SARS-CoV-2 epidemic><SARS-CoV-2 fatality><SARS-CoV-2 genome><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 induced death><SARS-CoV-2 induced fatality><SARS-CoV-2 induced mortality><SARS-CoV-2 mortality><SARS-CoV-2 pandemic><SARS-CoV-2 positive><SARS-CoV-2 positivity><SARS-CoV-2 related death><SARS-CoV-2 related fatality><SARS-CoV-2 related mortality><SARS-CoV-2 surveillance><SARS-CoV-2 testing><SARS-CoV-2 vaccination><SARS-CoV-2 variant><SARS-CoV-2 variant forms><SARS-CoV-2 variant strains><SARS-CoV2><SARS-CoV2 epidemic><SARS-CoV2 genome><SARS-CoV2 pandemic><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome coronavirus 2 positive><Severe acute respiratory syndrome coronavirus 2 positivity><Severe acute respiratory syndrome coronavirus 2 vaccination><Severe acute respiratory syndrome related corona virus 2><Social Service><Social Work><Specimen><Surveillance Program><Technology><Time><U.K. variant><UK variant><USPHS><United Kingdom><United Kingdom variant><United States><United States Centers for Disease Control><United States Centers for Disease Control and Prevention><United States Public Health Service><Universities><Variant><Variation><Wuhan coronavirus><adulthood><biological specimen archives><biosample archive><biospecimen archive><corona virus disease><corona virus disease 2019><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><coronavirus disease><coronavirus disease 2019><coronavirus disease 2019 associated death><coronavirus disease 2019 associated fatality><coronavirus disease 2019 associated mortality><coronavirus disease 2019 crisis><coronavirus disease 2019 death><coronavirus disease 2019 disparity><coronavirus disease 2019 epidemic><coronavirus disease 2019 fatality><coronavirus disease 2019 genome><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 induced death><coronavirus disease 2019 induced fatality><coronavirus disease 2019 induced mortality><coronavirus disease 2019 mortality><coronavirus disease 2019 pandemic><coronavirus disease 2019 positive><coronavirus disease 2019 positivity><coronavirus disease 2019 public health crisis><coronavirus disease 2019 related death><coronavirus disease 2019 related fatality><coronavirus disease 2019 related mortality><coronavirus disease 2019 surveillance><coronavirus disease 2019 testing><coronavirus disease 2019 vaccination><coronavirus disease 2019 variant><coronavirus disease 2019 variant forms><coronavirus disease 2019 variant strains><coronavirus disease 2019 virus><coronavirus disease 2019 virus genome><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><death due to COVID-19><death due to COVID19><death due to SARS-CoV-2><death due to coronavirus disease 2019><death due to severe acute respiratory syndrome coronavirus 2><death in COVID><death in COVID-19><death in SARS-CoV-2><death in coronavirus disease><death in coronavirus disease 2019><death in severe acute respiratory syndrome coronavirus 2><disparity in health><entire genome><epidemiologic><epidemiological><fatality due to COVID-19><fatality due to COVID19><fatality due to SARS-CoV-2><fatality due to coronavirus disease 2019><fatality due to severe acute respiratory syndrome coronavirus 2><fighting><full genome><genome sequencing><geographic site><hCoV19><health care personnel><health care professional shortage areas><health care worker><health disparity><health organization><health professional shortage areas><health provider><health workforce><healthcare personnel><heavy metal Pb><heavy metal lead><hospitalization rates><innovate><innovation><innovative><insight><interest><life-threatening COVID><life-threatening COVID-19><life-threatening SARS-CoV-2><life-threatening coronavirus disease><life-threatening coronavirus disease 2019><life-threatening severe acute respiratory syndrome coronavirus 2><medical personnel><mortality due to COVID-19><mortality due to COVID19><mortality due to SARS-CoV-2><mortality due to coronavirus disease 2019><mortality due to severe acute respiratory syndrome coronavirus 2><nCoV2><nano pore><nanopore><novel><pandemic><pandemic disease><population based><programs><prospective><response><sample archive><sequencing platform><serious COVID><serious COVID-19><serious SARS-CoV-2><serious coronavirus disease><serious coronavirus disease 2019><serious severe acute respiratory syndrome coronavirus 2><severe COVID><severe COVID-19><severe COVID19><severe SARS-CoV-2><severe acute respiratory syndrome coronavirus 2 B.1.1.7><severe acute respiratory syndrome coronavirus 2 associated death><severe acute respiratory syndrome coronavirus 2 associated fatality><severe acute respiratory syndrome coronavirus 2 associated mortality><severe acute respiratory syndrome coronavirus 2 death><severe acute respiratory syndrome coronavirus 2 fatality><severe acute respiratory syndrome coronavirus 2 genome><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome coronavirus 2 induced death><severe acute respiratory syndrome coronavirus 2 induced fatality><severe acute respiratory syndrome coronavirus 2 induced mortality><severe acute respiratory syndrome coronavirus 2 mortality><severe acute respiratory syndrome coronavirus 2 related death><severe acute respiratory syndrome coronavirus 2 related fatality><severe acute respiratory syndrome coronavirus 2 related mortality><severe acute respiratory syndrome coronavirus 2 surveillance><severe acute respiratory syndrome coronavirus 2 testing><severe acute respiratory syndrome coronavirus 2 variant><severe acute respiratory syndrome coronavirus 2 variant forms><severe acute respiratory syndrome coronavirus 2 variant strains><severe coronavirus disease><severe coronavirus disease 19><severe coronavirus disease 2019><severe severe acute respiratory syndrome coronavirus 2><specimen archive><treatment provider><tribal health><tribe health><vaccinate against COVID-19><vaccinate against COVID19><vaccinate against SARS-CoV-2><vaccinate against coronavirus disease 2019><vaccinate against severe acute respiratory syndrome coronavirus 2><vaccination against COVID-19><vaccination against COVID19><vaccination against SARS-CoV-2><vaccination against Severe acute respiratory syndrome coronavirus 2><vaccination against coronavirus disease 2019><vaccine efficacy><variant detection><variants of concern><virology><whole genome>